Practice-Changing Viral Hepatitis Data From AASLD 2022
Dec 06, 2022•8 min•Ep. 226
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:
- Novel therapeutics for HBV
- HCV management strategies
- HDV screening and linkage to care
- Fatty liver disease in persons with viral hepatitis
- Use of statins to decrease morbidity and mortality in persons with liver disease
Presenter:
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director
Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois
Link to full program:
https://bit.ly/3Y1tD6f
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android